| RS2116030992 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116031354 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116032687 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS2116032755 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS2116032944 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116033063 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116039575 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116039871 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116052322 |
GNAI1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, impaired speech |
| RS2116059096 |
PEX1
|
Health Risk |
Likely pathogenic |
— |
| RS2116059303 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116059937 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116059954 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116059968 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116062196 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116062284 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116064778 |
CDK13
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2116069671 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS2116069700 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116077400 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116077430 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116084282 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116085156 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS2116085331 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116091512 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116091859 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116094537 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 1A (Zellweger), Heimler syndrome 1 |
| RS2116095487 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2116098601 |
RALA
|
Health Risk |
Likely pathogenic |
— |
| RS2116098628 |
RALA
|
Health Risk |
Pathogenic |
Hiatt-Neu-Cooper neurodevelopmental syndrome, Hiatt-Neu-Cooper neurodevelopmental syndrome |
| RS2116098682 |
RALA
|
Health Risk |
Likely pathogenic |
Hiatt-Neu-Cooper neurodevelopmental syndrome, Hiatt-Neu-Cooper neurodevelopmental syndrome |
| RS2116098885 |
RALA
|
Health Risk |
Pathogenic |
Hiatt-Neu-Cooper neurodevelopmental syndrome, Hiatt-Neu-Cooper neurodevelopmental syndrome |
| RS2116098893 |
RALA
|
Health Risk |
Pathogenic |
Neurodevelopmental delay, Neurodevelopmental delay |
| RS2116102196 |
VPS41
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia, autosomal recessive 29 |
| RS2116110975 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116116365 |
CAV1
|
Health Risk |
Pathogenic |
Partial lipodystrophy, congenital cataracts |
| RS2116117201 |
CAV1
|
Health Risk |
Likely pathogenic |
Pulmonary hypertension, primary |
| RS2116129596 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, CFTR-related disorder |
| RS2116129829 |
CFTR
|
Health Risk |
Pathogenic |
Hereditary pancreatitis, Cystic fibrosis |
| RS2116132444 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS2116145117 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116145324 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116146598 |
KCND2
|
Health Risk |
Likely pathogenic |
— |
| RS2116155540 |
OGDH
|
Health Risk |
Pathogenic |
Oxoglutaricaciduria, Oxoglutaricaciduria |
| RS2116156265 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116156361 |
MDFIC
|
Health Risk |
Likely pathogenic |
— |
| RS2116163953 |
OGDH
|
Health Risk |
Pathogenic |
Oxoglutaricaciduria, Oxoglutaricaciduria |
| RS2116165809 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116165935 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116166262 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116166586 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116166673 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116166758 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116166806 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2116175944 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116180739 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116181485 |
PEX1
|
Health Risk |
Pathogenic |
Heimler syndrome 1, Heimler syndrome 1 |
| RS2116181877 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116201860 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS2116202376 |
COG5
|
Health Risk |
Pathogenic |
COG5-congenital disorder of glycosylation, COG5-congenital disorder of glycosylation |
| RS2116205361 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116206966 |
DLD
|
Health Risk |
Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116209376 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116219533 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116220618 |
CFTR
|
Health Risk |
Likely pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116220949 |
PEX1
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116221384 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116222206 |
LEP
|
Health Risk |
Pathogenic |
— |
| RS2116226142 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Bronchiectasis with or without elevated sweat chloride 1, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS2116226496 |
CFTR
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystic fibrosis, Bronchiectasis with or without elevated sweat chloride 1 |
| RS2116226651 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Cystic fibrosis |
| RS2116243800 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116244185 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Heimler syndrome 1 |
| RS2116245323 |
PEX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Zellweger spectrum disorders, Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116245705 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116247732 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 1A (Zellweger), Peroxisome biogenesis disorder 1A (Zellweger) |
| RS2116258970 |
PCLO
|
Health Risk |
Likely pathogenic |
— |
| RS2116268406 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS2116268939 |
CDK13
|
Health Risk |
Pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2116269944 |
PCLO
|
Health Risk |
Pathogenic |
— |
| RS2116271469 |
DLD
|
Health Risk |
Pathogenic/Likely pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116273912 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116277809 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS2116298327 |
PEX1
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder, Peroxisome biogenesis disorder |
| RS2116299216 |
PEX1
|
Health Risk |
Pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS2116300979 |
LAMB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, LEUKOENCEPHALOPATHY WITHOUT LACUNAE |
| RS2116309484 |
LAMB1
|
Health Risk |
Likely pathogenic |
— |
| RS2116310614 |
CDK13
|
Health Risk |
Likely pathogenic |
— |
| RS2116327253 |
LAMB1
|
Health Risk |
Likely pathogenic |
Cobblestone lissencephaly without muscular or ocular involvement, Cobblestone lissencephaly without muscular or ocular involvement |
| RS2116327525 |
CDK13
|
Health Risk |
Pathogenic |
— |
| RS2116327857 |
CDK13
|
Health Risk |
Likely pathogenic |
Congenital heart defects, dysmorphic facial features |
| RS2116347776 |
TSPAN12
|
Health Risk |
Likely pathogenic |
Exudative vitreoretinopathy 5, Exudative vitreoretinopathy 5 |
| RS2116347903 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS2116348265 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS2116348290 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS2116363345 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS2116363773 |
TSPAN12
|
Health Risk |
Pathogenic |
— |
| RS2116373070 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myotonia, autosomal recessive form |
| RS2116373517 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |
| RS2116374801 |
CLCN1
|
Health Risk |
Pathogenic |
Congenital myotonia, autosomal recessive form |